PCRX - Pacira Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue286,630276,371248,997
Cost of Revenue87,915110,10471,837
Gross Profit198,715166,267177,160
Operating Expenses
Research Development57,29045,67828,662
Selling General and Administrative166,362152,613139,043
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-24,937-32,0249,455
Income from Continuing Operations
Total Other Income/Expenses Net5131,241390
Earnings Before Interest and Taxes-24,424-30,7839,845
Interest Expense18,0477,0617,725
Income Before Tax-42,471-37,8442,120
Income Tax Expense140105264
Minority Interest---
Net Income From Continuing Ops-46,343-37,9491,804
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-42,611-37,9491,856
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-42,611-37,9491,856